Cargando…
Oncogenic effects of urotensin-II in cells lacking tuberous sclerosis complex-2
Lymphangioleiomyomatosis (LAM) is a destructive lung disease that can arise sporadically or in adults suffering from the tumor syndrome tuberous sclerosis complex (TSC). Microscopic tumors (‘LAM nodules’) in the lung interstitium arise from lymphatic invasion and metastasis. These consist of smooth...
Autores principales: | Goldberg, Alexander A., Joung, Kwang-Bo, Mansuri, Asma, Kang, Yujin, Echavarria, Raquel, Nikolajev, Ljiljana, Sun, Yang, Yu, Jane J., Laporte, Stephane A., Schwertani, Adel, Kristof, Arnold S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308642/ https://www.ncbi.nlm.nih.gov/pubmed/27458154 http://dx.doi.org/10.18632/oncotarget.10748 |
Ejemplares similares
-
A closer look at the role of urotensin II in the metabolic syndrome
por: Barrette, Pierre-Olivier, et al.
Publicado: (2012) -
The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification
por: Albanese, Isabella, et al.
Publicado: (2016) -
Potential Clinical Implications of the Urotensin II Receptor Antagonists
por: Tsoukas, Philip, et al.
Publicado: (2011) -
Urotensin II in cardiovascular regulation
por: Russell, Fraser D
Publicado: (2008) -
Central and Peripheral Effects of Urotensin II and Urotensin II-Related Peptides on Cardiac Baroreflex Sensitivity in Trout
por: Lancien, Frédéric, et al.
Publicado: (2017)